A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma - Editorial comment Journal Article


Author: Rusch, V. W.
Article Title: A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma - Editorial comment
Keywords: cancer chemotherapy; cancer survival; cancer surgery; cisplatin; doxorubicin; cancer growth; multimodality cancer therapy; treatment duration; treatment planning; note; gemcitabine; adjuvant therapy; cancer patient; cancer radiotherapy; chemotherapy, adjuvant; combined modality therapy; radiotherapy, adjuvant; research design; follow up; methodology; antineoplastic agent; interleukin 2; cancer immunotherapy; phase 2 clinical trial; antineoplastic combined chemotherapy protocols; disease severity; immunotherapy; adjuvant chemotherapy; long term care; pleura mesothelioma; mesothelioma; pleura tumor; decortication; pleurectomy; pleura; pleural neoplasms; interleukin-2; clinical trials, phase ii
Journal Title: European Journal of Cardio-Thoracic Surgery
Volume: 31
Issue: 3
ISSN: 1010-7940
Publisher: Oxford University Press  
Date Published: 2007-03-01
Start Page: 534
End Page: 535
Language: English
DOI: 10.1016/j.ejcts.2007.01.011
PUBMED: 17267238
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 17 November 2011" - "CODEN: EJCSE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Valerie W Rusch
    864 Rusch